Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

One expert explains what patients with prostate cancer interested in clinical trial participation need to know. For patients with prostate cancer who are interested in participating in clinical trials ...

India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

Application of canary histology classifier in prostate biopsies for risk stratification. Decipher genomic classifier (DGC) of early prostate cancer (EPC), and underlying transcriptomic profile (TP): ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

It does if a single state in the U.S. is any indication. In North Carolina, significantly higher rates of prostate cancer recurrence were reported among men living in rural areas compared to their ...